MENU
AUG 30, 2016 8:00 AM PDT

Translating Pluripotent Stem Cell Therapies For Focal Brain Disorders

Speaker

Abstract
A major challenge for the clinical application of pluripotent stem cell therapy for neurodegenerative diseases is large-scale manufacturing and cryopreservation of neurons and glia that can be prepared for surgery with minimal manipulation. To address this obstacle, midbrain dopamine (iPSC-mDA) and forebrain (iPSC-FB) lineage neurons were derived from human induced pluripotent stem cells and cryopreserved in large production lots for biochemical and transplantation studies. Cryopreserved, post-mitotic neurons retained high-viability with gene, protein, and electrophysiological signatures consistent with that of the neuronal lineage. To test therapeutic efficacy, cryopreserved iPSC-mDA neurons were transplanted without sub-culturing into the 6-OHDA-lesioned rat and MPTP-lesioned nonhuman-primate models of PD. Grafted neurons retained midbrain lineage with extensive innervation of both rodent and monkey brain with no aberrant growth. Behavioral assessment in parkinsonian rats demonstrated significant reversal in functional deficits up to 6-months post-transplantation. In addition, cryopreserved iPSC-FB neurons grafted into the striatum of athymic NUDE rats survived and innervated distant anterior and posterior brain structures at 9-months post-grafting. These findings demonstrate a simple and efficacious surgical intervention to deliver cryopreserved iPSC-derived neurons for brain disorders and support translational development of pluripotent cell-based therapies in neurodegenerative disease.
 

Show Resources
You May Also Like
APR 28, 2022 8:00 AM PDT
APR 28, 2022 8:00 AM PDT
Date: April 28, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Human pluripotent stem cells (PSCs) and their derivatives hold great potentials in...
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
JUN 01, 2022 9:00 AM PDT
JUN 01, 2022 9:00 AM PDT
Date: June 01, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) The manufacturing process for cell and gene therapies is complex and can contain process-related impurities from multiple...
JUN 28, 2022 7:00 AM PDT
JUN 28, 2022 7:00 AM PDT
Date: June 28, 2022 Time: 3:00pm (BST), 4:00pm (CET), 9:00am (CST), 7am (PST) Light-sheet microscopy is an extremely versatile imaging technique with a vast range of implementations that are...
MAR 16, 2022 8:00 AM PDT
C.E. CREDITS
MAR 16, 2022 8:00 AM PDT
Date: March 16, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CET) Handling of potent and/or hazardous substances is commonplace in sev.....
JUN 21, 2022 10:00 AM PDT
JUN 21, 2022 10:00 AM PDT
Date: June 21, 2022 Time: 10:00am (PDT), 1:00pm (EDT), 7:00pm (CEST) Human-induced pluripotent stem cell (iPSC) technology allows for “clinical trials in-a-dish” because patient...
Loading Comments...
Show Resources